Tobacco Cessation Treatment Preferences Among Veteran Smokers

Summary

There are significant barriers to tobacco cessation treatment for patients and providers in specialty care clinical settings. Specialty providers cite several barriers to delivering evidence-based tobacco cessation care, including insufficient time and lack of training. In addition, a large proportion of patients who begin tobacco cessation treatment do not quit. Use of healthcare technology (i.e., telehealth, electronic health record, and computerized treatment algorithms based on patient data) to improve patients' ability to quit tobacco use. The purpose of this study is to demonstrate the feasibility of a larger trial, and to evaluate the acceptability of the intervention design. Thirty participants will be assigned to receive either 1) a treatment that includes personalized counseling, tobacco cessation medications, and text messaging; or 2) referral to Department of Veterans Affairs' Quitline program plus SmokefreeVET, a text messaging program.

Conditions

• Tobacco Use

Interventions

BEHAVIORAL

Personalized Smoking Cessation Facilitation Meetings

Participants will participate in 5-7 meetings in which they will receive cognitive-behavioral therapy for tobacco cessation.

DRUG

Personalized Smoking Cessation Pharmacotherapy

Participants may receive pharmacotherapy for smoking cessation based on VA Pharmacy Benefits Management Services guidelines. Medications may include nicotine-replacement therapy, varenicline, and/or bupropion.

BEHAVIORAL

Personalized Text Messaging Support

If the participant has a working cell phone and is willing to receive text messages, supportive, personalized text messages will be sent to the participant starting after Session 1 and extending through 6 months post-quit using VA's Annie texting capability.

BEHAVIORAL

SmokefreeVET

Participants will receive a referral to SmokefreeVET, a text-messaging intervention designed to help veterans prepare for and attempt quitting smoking.

BEHAVIORAL

VA Quitline

Participants will receive a referral to VA Quitline, which is a nationally available telehealth intervention that provides assistance to veterans who wish to quit tobacco use. Quitline includes five sessions of cognitive-behavioral treatment.

OTHER

Education about pharmacotherapy

Participants will receive a handout that provides them with information about pharmacotherapies for tobacco cessation.

Sponsors & Collaborators

• VA Office of Research and Development

  lead FED

Principal Investigators

• Sarah M. Wilson, PhD · Durham VA Medical Center, Durham, NC

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2022-05-02

Primary Completion

2023-09-27

Completion

2023-09-27

FDA Drug

Yes

Countries

• United States

Study Locations